Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 26, 2023
Simulating a reference medium for determining bacterial growth in hospital wastewater for Raman spectroscopic investigationChristina Wichmann, Jennifer Dengler, Marc Hoffmann, et al.
Cureus|April 3, 2026
Bruton Tyrosine Kinase Inhibition in Combination With Bispecific Antibodies for Richter's Syndrome: A Report of Two Cases and Mini ReviewBen C Hane, Marc Hoffmann, Da Zhang, et al.
BMC Biology|March 4, 2014
Division in Escherichia coli is triggered by a size-sensing rather than a timing mechanismLydia Robert, Marc Hoffmann, Nathalie Krell, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 14, 2021
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infectionJoseph Bennett, Mark T Cunningham, Christin Howard, et al.
Cureus|June 23, 2025
Remission of Chimeric Antigen Receptor T-Cell-Refractory Diffuse Large B-Cell Lymphoma Resolved by Surgery and CD20 Bispecific TherapyVinny Lococo, Luke Selby, Rebecca Farmer, et al.
International Journal of Cancer|November 10, 2017
Chimeric antigen receptor transduced T cells: Tuning up for the next generationMaria-Luisa Schubert, Jean-Marc Hoffmann, Peter Dreger, et al.
Frontiers in Medicine|October 30, 2023
Toward a global harmonization of service infrastructure in academic clinical trial units: an international surveyJean-Marc Hoffmann, Anette Blümle, Regina Grossmann, et al.
Data in Brief|June 17, 2022
A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinomaRoman Ludwig, Jean-Marc Hoffmann, Bertrand Pouymayou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2022
Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interfaceRoman Ludwig, Jean-Marc Hoffmann, Bertrand Pouymayou, et al.
Human Gene Therapy|August 2, 2016
Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell TransplantationMaria-Luisa Schubert, Angela Hückelhoven, Jean-Marc Hoffmann, et al.
Pageof 5